title: Erythropoietin use in cancer patients: a matter of life and death?
authors.forename: David P
authors.initials: DP
authors.lastname: Steensma
authors.forename: Charles L
authors.initials: CL
authors.lastname: Loprinzi
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D011379:Prognosis; D011994:Recombinant Proteins; D012307:Risk Factors; D016019:Survival Analysis
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin